VEGFA and kidney disorder: In a nationwide Veterans Health Administration cohort of adults with type 2 DM, patients receiving intravitreal anti-VEGF injections had a higher 5-year incidence of systemic AEs and higher adjusted odds of incident kidney disease (Zafar et al., 2023).